Effect Of Iron and Folic Acid Supplementation and Parity on Maternal Hemoglobin and Neonatal Outcomes
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background: Maternal anemia remains a major public health concern in developing countries, particularly in India, where prevalence rates remain high despite national control programs. Iron and folic acid (IFA) supplementation is a key intervention aimed at reducing anemia and improving pregnancy outcomes. However, the combined influence of supplementation compliance, duration, and parity on maternal hemoglobin levels and neonatal outcomes requires further evaluation. Objective: To assess the effect of iron and folic acid supplementation and parity on maternal hemoglobin status and neonatal anthropometric outcomes in a tertiary care setting. Methods: A cross-sectional analytical study was conducted from July 2024 to July 2025 involving 500 term singleton mother–neonate dyads. Maternal hemoglobin levels in the first and third trimesters were obtained from antenatal records and categorized according to WHO criteria. Information regarding IFA supplementation and duration of intake was collected through record review and questionnaire. Neonatal birth weight, length, and head circumference were measured within 48 hours of birth using standardized techniques. Chi-square test, independent t-test, and one-way ANOVA were applied for statistical analysis. A p-value
Fields of Study & Subjects
Iron Metabolism and Disorders
Public Health and Nutrition
Maternal and Neonatal Healthcare
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 7 March 2026
- Language
- EN